Lyra Therapeutics, Inc. (LYRA)
OTCMKTS · Delayed Price · Currency is USD
0.2800
-0.0600 (-17.65%)
At close: Aug 10, 2026
Lyra Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -32.95 | -93.44 | -62.68 | -55.28 | -43.51 | -22.13 |
Depreciation & Amortization | 0.51 | 0.47 | 0.28 | 1.07 | 1 | 0.1 |
Stock-Based Compensation | 3.71 | 6.72 | 5.89 | 5.45 | 2.77 | 1.81 |
Other Adjustments | -0 | 22.58 | -1.9 | 0.82 | - | -0.05 |
Changes in Accounts Payable | -1.73 | -1.89 | 0.45 | -2.41 | 2.35 | 0.35 |
Changes in Accrued Expenses | -3.85 | -1.63 | 1.49 | 4.77 | 1.24 | -0.09 |
Changes in Unearned Revenue | -0.6 | -1.53 | -1.56 | 3.64 | 11.72 | - |
Changes in Other Operating Activities | 1.04 | -1.3 | -5.27 | -1.44 | -1.39 | -1.14 |
Operating Cash Flow | -34.15 | -70.01 | -63.3 | -43.39 | -25.82 | -21.14 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Capital Expenditures | 0.04 | -2.34 | -1.05 | -0.16 | -3.39 | -1.78 |
Sale of Property, Plant & Equipment | 0.01 | - | - | - | - | - |
Purchases of Investments | -6.4 | -47.95 | -122.42 | -64.84 | - | - |
Proceeds from Sale of Investments | 28.07 | 130.59 | 110.89 | - | - | - |
Investing Cash Flow | 28.13 | 80.31 | -12.58 | -65.01 | -3.39 | -1.78 |
Issuance of Common Stock | 5 | 8.82 | 69.35 | 100.5 | 0.6 | 59.9 |
Net Common Stock Issued (Repurchased) | 5 | 8.82 | 69.35 | 100.5 | 0.6 | 59.9 |
Issuance of Preferred Stock | - | - | - | - | - | 30.39 |
Net Preferred Stock Issued (Repurchased) | - | - | - | - | - | 30.39 |
Other Financing Activities | -0.74 | -0.29 | -3.65 | -4.25 | -0.25 | -2.59 |
Financing Cash Flow | 4.27 | 8.53 | 65.69 | 96.26 | 0.36 | 87.7 |
Net Cash Flow | -1.74 | 18.83 | -10.2 | -12.13 | -28.85 | 64.79 |
Free Cash Flow | -34.11 | -72.35 | -64.35 | -43.55 | -29.21 | -22.92 |
Free Cash Flow Growth | - | - | - | - | - | - |
FCF Margin | -5684.50% | -4716.36% | -4130.36% | -3195.08% | -10247.37% | - |
Free Cash Flow Per Share | -23.76 | -55.56 | -64.60 | -72.02 | -112.45 | -133.40 |
Levered Free Cash Flow | -37.54 | -101.65 | -68.33 | -49.82 | -31.98 | -24.69 |
Unlevered Free Cash Flow | -39.89 | -104.52 | -72.71 | -50.83 | -32.08 | -24.77 |